Wanna bet the posters on this MB are not the only ones who see this potential A2-73 conditional connection to a vital humanitarian/medical need? Now if I was a really clever big league top shelf bio-medical investor/analyst I would like to understand more. BTW, since the risk of not doing something at this point is massive and considering additional mitigation detailed trials are already certain to follow then the motivation to overcome inertia is bigly.